Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Belinda S Parker"'
Autor:
Damien J Zanker, Alex J Spurling, Natasha K Brockwell, Katie L Owen, Jasmine M Zakhour, Tina Robinson, Hendrika M Duivenvoorden, Paul J Hertzog, Stefanie R Mullins, Robert W Wilkinson, Belinda S Parker
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Abstract Objectives Loss of tumor‐inherent type I interferon (IFN) signalling has been closely linked to accelerated metastatic progression via decreased immunogenicity and antitumor immunity. Previous studies in murine models of triple‐negative
Externí odkaz:
https://doaj.org/article/61578605bee846698ae1d74398aee779
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201370 (2018)
Mammographic screening has led to increased detection of breast cancer at a pre-invasive state, hence modelling the earliest stages of breast cancer invasion is important in defining candidate biomarkers to predict risk of relapse. Discrimination of
Externí odkaz:
https://doaj.org/article/e51181b0739540b5be9abfa1c0fd9611
Autor:
Louise A. Baldwin, Nenad Bartonicek, Jessica Yang, Sunny Z. Wu, Niantao Deng, Daniel L. Roden, Chia-Ling Chan, Ghamdan Al-Eryani, Damien J. Zanker, Belinda S. Parker, Alexander Swarbrick, Simon Junankar
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Understanding the molecular mechanisms of cancer immunoediting could provide insight into resistance to immunotherapy. Here, DNA barcoding provides evidence of ongoing immunoediting during metastasis and treatment with anti-PD1 and anti-CTLA4, and id
Externí odkaz:
https://doaj.org/article/65c4b7296f594b7ab39104a26aaa50c8
Autor:
Louise Kostos, James P. Buteau, Theresa Yeung, Juliana Di Iulio, Jing Xie, Anthony Cardin, Kwang Y. Chin, Brittany Emmerson, Katie L. Owen, Belinda S. Parker, Heidi Fettke, Luc Furic, Arun A. Azad, Michael S. Hofman
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background[177Lu]Lu-PSMA is a radioligand therapy used in metastatic castration-resistant prostate cancer (mCRPC). Despite a survival benefit, the responses for many patients receiving [177Lu]Lu-PSMA are not durable, and all patients eventually devel
Externí odkaz:
https://doaj.org/article/ee75493d95874a12b67e6d0f0cb88f42
Autor:
Belinda S. Parker, Andreas Möller, Daniel M. Andrews, Paul J. Hertzog, Robin L. Anderson, Weisan Chen, Christina S. Wong, Peter Lock, Edwin D. Hawkins, Erin C. Lucas, Bradley N. Bidwell, Kun Xiao, Krishnath M. Jayatilleke, Clare Y. Slaney, Nikola Baschuk, Jai Rautela
Supplementary Figure Legend from Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb9a19b9f3fa6271368bbbcc7452cfd
https://doi.org/10.1158/2326-6066.22537147
https://doi.org/10.1158/2326-6066.22537147
Autor:
Robin L. Anderson, Jane M. Moseley, Erica K. Sloan, Kym L. Stanley, Michael D. Tavaria, Anthony L. Natoli, Christina M. Restall, Ryan K. van Laar, Belinda S. Parker, Bedrich L. Eckhardt
Primer sequences used in realtime quantitative PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9b7395b67406243fa525ee3346ff09
https://doi.org/10.1158/1541-7786.22520646.v1
https://doi.org/10.1158/1541-7786.22520646.v1
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
Figure legends for supplementary figures 1, 2 & 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3499bd9355a04dac47fccd01d1025b6
https://doi.org/10.1158/2326-6066.22537178.v1
https://doi.org/10.1158/2326-6066.22537178.v1
Autor:
Robin L. Anderson, Jane M. Moseley, Erica K. Sloan, Kym L. Stanley, Michael D. Tavaria, Anthony L. Natoli, Christina M. Restall, Ryan K. van Laar, Belinda S. Parker, Bedrich L. Eckhardt
Genes altered between highly and weakly metastatic tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0545800c2f49830f3938d8c25718e13c
https://doi.org/10.1158/1541-7786.22520640
https://doi.org/10.1158/1541-7786.22520640
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
The effect of combination treatment on T cell activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d4f94fe5a5e07717a1c3e0e4da0cb1a
https://doi.org/10.1158/2326-6066.22537181.v1
https://doi.org/10.1158/2326-6066.22537181.v1
Autor:
Belinda S. Parker, Elgene Lim, Phillip K. Darcy, Sherene Loi, Franco Caramia, Nikola Baschuk, Hendrika M. Duivenvoorden, Jai Rautela, Alex Spurling, Damien Zanker, Katie L. Owen, Natasha K. Brockwell
The lack of targeted therapies available for triple-negative breast cancer (TNBC) patients who fail to respond to first-line chemotherapy has sparked interest in immunotherapeutic approaches. However, trials utilizing checkpoint inhibitors targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12dc36d7bdeb3d3c3e14c923091f5dc9
https://doi.org/10.1158/2326-6066.c.6548339.v1
https://doi.org/10.1158/2326-6066.c.6548339.v1